A Wall Street analyst has provided a review for the Services company today, but retained the same rating on the
Tag: GBT
H.C. Wainwright Maintains Their Buy Rating on Global Blood Therapeutics (GBT)
In a report released today, Debjit Chattopadhyay from H.C. Wainwright maintained a Buy rating on Global Blood Therapeutics (GBT –
Global Blood Therapeutics (GBT) Gets a Buy Rating from William Blair
William Blair analyst Raju Prasad maintained a Buy rating on Global Blood Therapeutics (GBT – Research Report) today. The company’s
Global Blood Therapeutics (GBT) Received its Third Buy in a Row
After William Blair and Wedbush gave Global Blood Therapeutics (NASDAQ: GBT) a Buy rating last month, the company received another
Wedbush Believes Global Blood Therapeutics (NASDAQ: GBT) Still Has Room to Grow
Wedbush analyst Liana Moussatos reiterated a Buy rating on Global Blood Therapeutics (GBT – Research Report) today and set a
Wedbush Believes Global Blood Therapeutics (NASDAQ: GBT) Still Has Room to Grow
In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Global Blood Therapeutics (GBT – Research
William Blair Maintains a Buy Rating on Global Blood Therapeutics (GBT)
In a report released today, Raju Prasad from William Blair maintained a Buy rating on Global Blood Therapeutics (GBT –